Bright Minds Biosciences
DRUG • NASDAQ
Bright Minds Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ian McDonald, with a market cap of $686.1M.
CEOIan McDonald
Next Earnings
Upcoming earnings announcement for Bright Minds Biosciences
Date
Thursday, May 14, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q2 2026
EPS Estimate
-$1.55
Earnings History
Past 7 earnings reports for Bright Minds Biosciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Aug 11, 2025 | Q3 2025 | -$0.42Est: -$0.59 | +28.8% | - | — | — |
| May 15, 2025 | Q2 2025 | -$0.29 | — | - | — | — |
| Feb 14, 2025 | Q1 2025 | $0.01 | — | - | — | — |
| Dec 31, 2024 | Q4 2024 | -$0.12 | — | - | — | — |
| Aug 14, 2024 | Q3 2024 | $0.05 | — | - | — | — |
| May 17, 2024 | Q2 2024 | -$0.13 | — | - | — | — |
| Feb 13, 2024 | Q1 2024 | -$0.44 | — | - | — | — |